If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



Keep up the objective reporting

February 20, 2017 | A version of this story appeared in Volume 95, Issue 8

I have been an ACS member for over 10 years and thoroughly enjoy reading C&EN. I have a Ph.D. in biochemistry and an interest in politics. I have always appreciated the manner in which C&EN reports on political issues by focusing on the science and the facts.

I am also a strong Donald J. Trump supporter. In the current media climate, I was happy to see that the Jan. 16 issue kept with C&EN’s tradition of objective reporting (C&EN, Jan. 16, page 24). I assume that many journalists do not support the current President and likely enjoy writing hit pieces or treating our President unfairly.

I just wanted to let you know that I appreciate the objective reporting of C&EN and that there are well-educated Trump supporters who read your magazine. Keep up the good work!

Chris Spedaliere
Malvern, Pa.


Jan. 30, page 27: The feature story about China’s investments in new light sources incorrectly described a field served by synchrotrons as condensed metaphysics. The field is condensed matter physics.

Feb. 13, page 28: The cover story about the challenge of delivering CRISPR inside the body incorrectly stated that Casebia Therapeutics is a joint venture between Novartis and CRISPR Therapeutics. It is a joint venture between Bayer and CRISPR Therapeutics.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.